Chair of Medicines and Healthcare products Regulatory Agency (MHRA) - VAC-1679 Copy

Body: Medicines and Healthcare products Regulatory Agency (MHRA)
Appointing Department: Department of Health
Sector: Health
Location: London
Number of Vacancies: 1
Remuneration: Remuneration is £63,000 per annum
Time Requirements: 2 to 3 days per week. Board meetings dates are generally arranged for the third Monday of every month.

Campaign Timeline

  • Competition Launched


  • Closed for Applications


  • Panel Sift


  • Final Interview Date


  • Announcement



Assessment Panel

Vacancy Description

Role and Responsibilities of the Chair

The Chair of the MHRA is accountable to the Secretary of State for Health and Social Care and will:

  • Provide strong leadership, challenge and direction to the organisation, encouraging and enabling the MHRA to be a first-class regulator of medicines and medical devices, building on its international status and leading the Agency through the changes to come now we have left the European Union.
  • In partnership with the Executive Team and Board members, ensure that the MHRA drives a major multi-year operational transformation programme, within the agreed financial envelope, delivering significant changes to fundamentally reshape the way the Agency operates, including driving efficiencies throughout the business.
  • Ensure high standards of governance and effectiveness, encourage and enabling non-executive directors to make a full contribution to the Board’s affairs, making best use of their varied skills and diverse backgrounds, and advising the Department of Health and Social Care on their performance.
  • In partnership with the Chief Executive, set the tone for excellent working relationships between the three centres that comprise the MHRA, as well as between the MHRA and key stakeholders. Ensure that policy and operational decisions reflect the needs and views of stakeholders, including patients, the public, NHS and industry to deliver confidence in the work of the Agency during challenging times.
  • Progress the Agency’s innovation agenda creatively and effectively, seeking new opportunities and delivering on the Agency’s commitments to support the Government’s Strategy for UK Life Sciences.

Person Specification

Qualities required for the role of the Chair

The Department of Health and Social Care values and promotes diversity and encourages applications from all sections of the community. The boards of public bodies should reflect the population they are there to serve. Boards also benefit from fresh perspectives, and we are always keen to encourage candidates with private sector experience to consider applying for our roles.

Essential Criteria

To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.

  • A career record of achievements in the life sciences sector, or transferable experience from an alternative regulatory sector, of scale and relevance consistent with being the Chair of MHRA.
  • Ability to support innovation in the sector while safeguarding the independence and rigour of MHRA in protecting public health.
    • Exemplary governance, organisational and transformational leadership skills, able to lead the board of a significant national public body through substantial change within a large, complex system.
  • Excellent communicator, able to gain the confidence of and build successful alliances with a range of stakeholders, both domestic and international, and including Ministers.

Additional Information

The Medicines and Healthcare products Regulatory Agency’s role and responsibilities

“This is a pivotal time in the Agency’s history and we are in the process of organisational transformation to enhance our vital role in the safeguarding of public health. During the coming three years the Chair will play a key role as the Agency delivers an ambitious business change programme which will help maintain the UK as a global centre of excellence in medical science, in the best interests of patients and the public.”

Dr June Raine, CEO of MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. It is an executive agency, sponsored by the Department of Health and Social Care. The Agency employs more than 1,300 people and has facilities in London, York and South Mimms in Hertfordshire.

Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development.

The agency has three centres:

  • The Clinical Practice Research Datalink (CPRD), a data research service that aims to improve public health by using anonymised NHS clinical data.
  • The National Institute for Biological Standards and Control (NIBSC), a global leader in the standardisation and control of biological medicines.
  • The Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness.

The agency is responsible for:

  • Ensuring that medicines, medical devices and blood components for transfusion meet applicable standards of safety, quality and efficacy.
  • Ensuring that the supply chain for medicines, medical devices and blood components is safe and secure.
  • Promoting international standardisation and harmonisation to assure the effectiveness and safety of biological medicines.
  • Helping to educate the public and healthcare professionals about the risks and benefits of medicines, medical devices and blood components, leading to safer and more effective use.
  • Supporting innovation and research and development that’s beneficial to public health.
  • Influencing UK and international regulatory frameworks so that they’re risk-proportionate and effective at protecting public health.

MHRA’s current priorities

  • Lead development of the UK’s approach to regulation of medicines and medical devices, following the UK’s departure from the European Union, strengthening MHRA’s global role and influence.
  • Drive an ambitious transformation plan throughout the Agency to deliver a more flexible and efficient organisation, using state-of-art digital technology, able to respond effectively to market and customer requirements.
  • Develop regulation which supports transformational innovation and the safe manufacture, sale and supply of medicines and medical devices.
  • Support the government’s growth agenda through the life science strategy and sector deal commitments, which include early access to medicines schemes and the adaptive licensing pilot.
  • Contribute to system wide response to the Independent Medicines & Medical Devices Safety (IMMDS) review, including a fundamental review of MHRA’s engagement with patients and the public to improve public health and patient safety.

 The MHRA Board

The MHRA operates a unitary Board, the role of which is to provide strategic advice on the running of the Agency, ensuring that effective arrangements are in place to:

  • Provide assurance and review the controls needed for effective risk management, governance and internal control.
  • Demonstrate sound financial management and good value for money.
  • Ensure that the Agency has the capability to deliver.

Specifically, the Board is collectively responsible for the following:

  • Agreeing the strategic aims and objectives of the Agency, consistent with its overall strategic direction and within the policy and resources framework determined by the Secretary of State.
  • Endorsing the Agency’s recommendations to Ministers on the Agency’s key financial and performance targets and the Agency’s annual business plan and five-year corporate plan.
  • Agreeing the content of the Agency’s annual report to be proposed to Ministers.
  • Advising on and monitoring:
    • The implementation of strategies to ensure that the regulatory systems for medicines and medical devices are effective and robust, given developments in science and technology, at a UK and international level;
    • The implementation of strategies for increasing public knowledge and understanding about the safe use of medicines and medical devices
    • The service provided to the manufacturers of medicines and medical devices, to health and social care professionals and to the general public
    • The steps taken by the Agency to protect the interests of the public by ensuring that medicines meet appropriate standards of safety, quality and efficacy and that medical devices meet appropriate standards of safety, quality and performance; and
    • The steps taken by the Agency to support innovation and growth and the impact these have had on public health.

How to Apply

Making an application

Thank you for your interest in the appointment of the Chair to the MHRA.

To make an application please email your CV, a supporting letter and completed monitoring forms to: – please quote VAC-1679 in the subject field.

If you are unable to apply by email you may send your application by post to:

Kuldeep Kanda Department of Health and Social Care, Room 1N09, Quarry House, Quarry Hill, Leeds, LS2 7UE

Applications must be received by midday on 8th April 2020.

In making an application please note the following:

Supporting letter

The supporting letter is your opportunity to demonstrate how you meet each of the criteria set out in the person specification. It will benefit the Advisory Assessment Panel if you can be clear which specific evidence you provide relates to which criteria. Providing separate paragraphs in relation to each criterion is common practice. Please write all acronyms in full first.

Please ensure your full name, the role to which you are applying and the corresponding reference number for the post are clearly noted at the top of your letter.

Please limit your letter to two pages, and type or write clearly in black ink.

Conflicts of interest

If you have any business or personal interests that might be relevant to the work of the MHRA, and which could lead to a real or perceived conflict of interest if you were to be appointed, please provide details in your supporting letter.

If appointed, you will also be required to declare these interests on appointment and they will be entered on a register which is available to the public.

Standards in public life and ensuring public confidence

Given the nature of public appointments, it is important that those appointed as members of public bodies maintain the confidence of the public and Government. If there are any issues in your personal or professional history (including any convictions or bankruptcy) that could, if you were appointed, be misconstrued, cause embarrassment to Ministers or MHRA or cause public confidence in the appointment to be jeopardised, it is important that you bring them to the attention of the Assessment Panel and provide details of the issue/s in your Supporting letter. In considering whether you wish to declare any issues, you should also reflect on any public statements you have made, including through social media and blogs. Due Diligence may be carried out on any publicly available information and shared with the Advisory Assessment Panel.

The panel may explore any issues you declare with you before they make a recommendation on the appointment.

Failure to disclose such information could result in an appointment being terminated, as those who hold public appointments are expected to demonstrate the highest standards of corporate and personal conduct and are required to subscribe to the Code of Conduct for Board Members of Public Bodies, as part of agreeing to the terms and conditions of appointment. You can access this document at:

There are also circumstances in which individuals may not be considered for appointment, due to them not meeting certain eligibility criteria for appointment. For further information, please refer to Section 2.3: Eligibility Criteria

If you wish to discuss any queries on conflicts, please see the contacts section.


Please ensure your CV includes:

  • Your full name, title, home address, personal contact telephone numbers (land line and mobile), personal email address and details of any twitter accounts and LinkedIn accounts including your twitter handle/username.
  • Similar contact details for two referees who will support your application. One referee should be the person to whom you are/were accountable in your current/most recent appointment or position of employment. Please indicate the relationship of each referee to you. References will be requested for short-listed candidates prior to interview.
  • Brief details of your current or most recent post and the dates you occupied this role. Please identify any past or present Ministerial appointments.

Monitoring form

Please complete the monitoring form. Diversity monitoring information will not be seen by the Advisory Assessment Panel assessing your application.

Political activity information is primarily for monitoring purposes only, however if you are shortlisted for interview, this information will be shared with the selection panel. The reason for this is that it is appreciated that such activities may have given you relevant skills, including experience gained from committee work, collective decision-making, resolving conflict and public speaking. If you have had such experience and you consider it relevant to your application for this post, you should also take the opportunity to include it separately in your supporting statement. If possible, you should not, however, identify the relevant political party in your statement.

Guaranteed Interview Scheme

The Department of Health and Social Care operates a Guaranteed Interview Scheme (GIS) for disabled people. The Equality Act 2010 defines a person as disabled if they have a physical or mental impairment and the impairment has a substantial and long-term adverse effect on their ability to carry out normal day to day activities. Under the GIS a disabled candidate will be selected for interview if they meet the essential criteria for the post.

If you wish to apply under the GIS please complete the GIS form and return it with your application.

All applications will be acknowledged by email after the closing date.


For further information regarding the selection process, please contact

Kully Kanda

Appointments Team

Tel: 0113 2545929


For further information regarding the role of the MHRA and the role of the Chair please contact:

Elizabeth Woodeson via Ty Vuong:


Please quote reference VAC-1679 on all correspondence.

If you choose to apply, we would like to thank you in advance for your time and effort in making an application.

15. GIS_Form
Monitoring Form
April Closing Date MHRA Chair Candidate Information Pack final
April Closing Date Advert Final

This post is NOT regulated by The Commissioner for Public Appointments.

Return to Search